No ownership or control links for Li Dean Y are resolved in the current sources yet — view the network graph to expand, or pull the cited JSON dossier.

What is Li Dean Y's risk level?

WhiteIntel flags Li Dean Y as low risk. Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership.

Where does Li Dean Y appear across sources?

Li Dean Y is indexed in the WhiteIntel corporate-ownership graph (US), with a source on every claim.

LIVE · CORPUS

PersonLow

Li Dean Y

Name: Li Dean Y — ownership dossier
Creator: WhiteIntel
License: https://whiteintel.dev/terms
Keywords: corporate ownership, beneficial ownership, UBO, corporate intelligence, OSINT, corporate registry, Li Dean Y, Person, US

Li Dean Y — US person (sec:0001837016). 4 holdings. Every claim linked to its source.

controls 4 companies

Ownership graph Export .md

JSON / MCPsample

The finding

Controls or directs 4 companies in the resolved graph.

Investigative lead by resolved identity, not a legal determination.

/01

Registry identity

Controls: 4 companies
Risk: Low
Jurisdiction: US

/02

Control & directorships

Links are shown as observed in a source registry — we do not currently hold ownership end dates, so a link here may since have ended. Each row carries its source; check it before relying on currency.

Controlled by

None in current sources.

Directorships & controlled companies

Li Dean Y
- Merck & Co., Inc.· officer· via SEC EDGAR (Form 3/4/5)
- RECURSION PHARMACEUTICALS, INC.· director· via SEC EDGAR (Form 3/4/5)

Nothing further is withheld here. The ownership and control links above are everything we have resolved for Li Dean Y — there is no deeper chain behind a paywall. Absence means “not observed in our current sources” — it is not a finding of none.

Monitoring

Coverage of Li Dean Y is still thin in the current sources. Watch it and we'll flag the moment new ownership, filings or risk signals land.

Explore US coverage

WHAT YOU CAN SEEFREE

YOURS NOW · FREE

4 items you can read right now — no account, no payment.

Identity, nationality & aliases
Sanctions, PEP & watchlist detail
Direct connections (1 hop)
Community notes

Nothing further on Li Dean Y is behind a paywall — everything we hold on this subject is already on this page.

/03

People & control

2 parties · 0 current

Every officer, person with significant control and cross-company role we hold, resolved into one entry per party. Roles are registry records, not a claim of control.

●
Merck & Co., Inc.
Also holds roles at 110 other companies
- Oosthuizen Johannes Jacobusofficer
- Williams David Michaelofficer
- THULIN INGE Gdirector
●
RECURSION PHARMACEUTICALS, INC.
Also holds roles at 45 other companies
- Gibson Christopherofficer
- Taylor Ben Rofficer
- Bumpus Namandjedirector

2 parties · 0 current. Ceased and resigned records are retained as history.

/04

Common questions

Who owns Li Dean Y?: No ownership or control links for Li Dean Y are resolved in the current sources yet — view the network graph to expand, or pull the cited JSON dossier.
What is Li Dean Y's risk level?: WhiteIntel flags Li Dean Y as low risk. Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership.
Where does Li Dean Y appear across sources?: Li Dean Y is indexed in the WhiteIntel corporate-ownership graph (US), with a source on every claim.

Community intel

Crowd leads · unverified

Tips, corrections and leads contributed by the community on Li Dean Y. These are unverified leads, not WhiteIntel findings — we surface them for investigators to chase, and analyse the corroborated ones into SnitchScore.

Loading tips…